• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Pharma industry news

DNA sequencing

Two thirds of Britons would have genetic test to identify risk of disease if it were free on the NHS

Posted on: 29 January 2015 | Source: The Astellas Innovation Debate

Two thirds (66%) of the population would want to know whether they had a risk of developing a serious illness, such as cancer, if genetic testing were available for free on the NHS...

AstraZeneca announces collaborations to use CRISPR technology for genome editing across its drug discovery platform

AstraZeneca announces four collaborations to use CRISPR technology for genome editing across its drug discovery platform

Posted on: 29 January 2015 | Source: AstraZeneca

AstraZeneca has announced 4 research collaborations aimed at harnessing CRISPR, a pioneering genome-editing technique, across its entire discovery platform...

Frost & Sullivan

European Hantavirus diagnostics market tops US market as a result of higher disease prevalence

Posted on: 28 January 2015 | Source: Frost & Sullivan

Frost & Sullivan says existing competitors’ dominance of the niche market raises entry barriers...

Roche logo

Roche delivers solid results in 2014

Posted on: 28 January 2015 | Source: Roche

Commenting on the Group’s results, Roche CEO Severin Schwan said: “We made good progress in 2014 with solid growth in both divisions driven by our newly launched medicines and diagnostic tests..."

Health Tech

Screen time, not face time

Posted on: 28 January 2015 | Source: The Astellas Innovation Debate

British patients happy to have webcam consultations – especially the over 55s...

GlobalData

Sparse pipeline for acromegaly and gigantism treatment limiting market growth, says GlobalData

Posted on: 28 January 2015 | Source: GlobalData

The acromegaly and gigantism treatment market will expand at a modest Compound Annual Growth Rate (CAGR) of 3.74% from approximately $588 million in 2013 to $707 million by 2018, limited by a sparse pipeline, according to research and consulting firm GlobalData...

Bristol Myers Squibb logo

Bristol-Myers Squibb reports fourth quarter and full year 2014 financial results

Posted on: 28 January 2015 | Source: Bristol-Myers Squibb Company

Bristol-Myers Squibb Company reported results for the fourth quarter and full year of 2014, which were highlighted by strong global sales for priority brands and important advances in the company’s immuno-oncology (I-O) portfolio...

Provepharm

Provepharm launches ProveDye®, its first medical device, in Europe

Posted on: 28 January 2015 | Source: Andrew Lloyd & Associates

ProveDye is a new sterile solution of methylene blue designed to aid visualization in surgical procedures. With ProveDye, Provepharm extends the Proveblue® methylene blue compound product range...

Frost & Sullivan

Interoperable electronic health records can revolutionize healthcare delivery in Europe

Posted on: 27 January 2015 | Source: Frost & Sullivan

Country-specific EHR implementation strategies will expedite market development, says Frost & Sullivan...

Actavis logo

Actavis to acquire Auden Mckenzie for £306m

Posted on: 27 January 2015 | Source: Actavis

Actavis plc and the owners of Auden Mckenzie Holdings Limited, a dynamic and fast growing company focused on the development, licensing and marketing of niche generic medicines and proprietary brands in the UK, announced that they have reached a definitive agreement, under which Actavis will acquire Auden Mckenzie for approximately £306 million in cash...

Health Tech

Health data may not make your boss ‘app-y

Posted on: 27 January 2015 | Source: Lukats and Shapiro

Half of UK bosses tempted to snoop on employees health app data to catch them ‘pulling a sickie’...

Health Consumer Powerhouse

The 2014 Euro Health Consumer Index

Posted on: 27 January 2015 | Source: Health Consumer Powerhouse

In spite of financial crisis, European healthcare keeps improving – but the equity gap widens...